Wani Gh Mohiuddin, Ahmad Sheikh Manzoor, Khursheed Bilques
Department of Dermatology, Venereology and Leprosy, Sheri-Kashmir Institute of Medical Sciences (SKIMS), Medical College Hospital, Srinagar, Kashmir, India.
Indian Dermatol Online J. 2015 Nov-Dec;6(6):387-92. doi: 10.4103/2229-5178.169732.
Cutaneous leishmaniasis (CL) is an infectious disease of tropical and semitropical areas of the world. The cold and harsh winter conditions of the Kashmir Valley do not favor the survival and growth of the Leishmania parasite or its vector, the sand fly, and the disease was until now practically unheard of in the Kashmir Valley.
There has been a recent rise in the number of cases of CL in the Kashmir Valley. Against this background, the present study was taken up to describe the epidemiology, clinical features, and management outcomes of CL in the Kashmir Valley, where it represents a new phenomenon.
Patients with direct smear-confirmed CL were evaluated. For each patient, we noted age, gender, geographical origin, stays in endemic areas, clinical aspects, number, site and size of lesions, treatment, and outcome. All the infected patients were treated with sodium stibogluconate. The dose, route of administration, adverse effects, and the clinical response in each patient was noted down.
Eighteen patients, 11 males (61.12%) and 7 females (38.88%) were studied. The age of the patients ranged from 3 to 60 years (mean age 29.8). The majority of our patients (16, 88.9%) belonged to two hilly areas, Uri and Karnah. Duration of the disease ranged from a minimum of 1 month to a maximum of 18 months (mean duration 4.6 months). Lesions in most of our patients (16, 88.9%) were located on the face including the lip and nose. The size of lesions varied from 4 to about 50 mm (average 2-3 cm). Most of our patients (13, 73.3%) had only a single lesion and a few (5, 26.7%) had two or three lesions. The clinical type of lesion in most of our patients (16, 88.9%) was noduloulcerative, only two (11.1%) had nodular (nonulcerative) lesions. Sixteen patients; all with facial lesions were treated with intravenous sodium stibogluconate. A complete response was seen in 14 (87%), without any major adverse effect. Two adult patients with extrafacial lesions were treated with four doses of weekly intralesional injections of sodium stibogluconate. A complete response was seen in both, without any major adverse effect.
The emergence of CL in this nonendemic area is of great epidemiological importance. Because no parasite isolation and characterization was carried out, further epidemiological studies and taxonomic differentiation of the species are required.
皮肤利什曼病(CL)是一种发生于世界热带和亚热带地区的传染病。克什米尔山谷寒冷恶劣的冬季条件不利于利什曼原虫寄生虫或其传播媒介白蛉的生存和生长,因此到目前为止,克什米尔山谷几乎从未听说过这种疾病。
最近克什米尔山谷的CL病例数有所上升。在此背景下,本研究旨在描述克什米尔山谷这种新出现现象的CL的流行病学、临床特征及治疗结果。
对直接涂片确诊为CL的患者进行评估。对于每位患者,我们记录了年龄、性别、地理来源、在流行地区的停留时间、临床情况、病变数量、部位和大小、治疗方法及结果。所有感染患者均接受葡萄糖酸锑钠治疗。记录每位患者的剂量、给药途径、不良反应及临床反应。
共研究了18例患者,其中男性11例(61.12%),女性7例(38.88%)。患者年龄在3至60岁之间(平均年龄29.8岁)。大多数患者(16例,88.9%)来自两个山区,乌里和卡尔纳。病程最短1个月,最长18个月(平均病程4.6个月)。大多数患者(16例,88.9%)的病变位于面部,包括嘴唇和鼻子。病变大小从4毫米到约50毫米不等(平均2 - 3厘米)。大多数患者(13例,73.3%)只有单个病变,少数(5例,26.7%)有两个或三个病变。大多数患者(16例,88.9%)的临床病变类型为结节溃疡性,只有两例(11.1%)为结节性(非溃疡性)病变。16例面部有病变的患者接受了静脉注射葡萄糖酸锑钠治疗。14例(87%)完全缓解,无任何严重不良反应。两名面部以外有病变的成年患者接受了每周4次的病灶内注射葡萄糖酸锑钠治疗。两人均完全缓解,无任何严重不良反应。
这种非流行地区出现CL具有重要的流行病学意义。由于未进行寄生虫分离和鉴定,需要进一步开展流行病学研究及该物种的分类鉴别。